J Korean Med Assoc Search


J Korean Med Assoc > Volume 52(7); 2009 > Article
Journal of the Korean Medical Association 2009;52(7):657-664.
DOI: https://doi.org/10.5124/jkma.2009.52.7.657   
Recent Advance in Rheumatoid Arthritis
Hyeok Jae Ko, Ho Youn Kim
Department of Rheumatology, The Catholic University of Korea College of Medicine, Korea. kohj8804@catholic.ac.kr, ho0919@catholic.ac.kr
ARheumatoid arthritis is a systemic, inflammatory, autoimmune disorder of unknown origins. Enhanced understanding of molecular pathogenesis has enabled the development of new biologic treatment that focuses on selective parts of immune system. Combined genetic and environmental factors in association with the risk of rheumatoid arthritis have received increased attention. Research undertaken on the longitudinal disease process and molecular pathology of joint inflammation has contributed to the development of new therapeutic strategies that promote early use of disease-modifying anti-rheumatic drugs (DMARDs) with tight disease control and measurable treatment outcome. Such approach can be beneficial for control of inflammatory activity and joint destruction. We need to find out how to tailor the best individualized treatment in accordance with different cases.
Key Words: Rheumatoid arthritis, Inflammation, DMARDs


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@kma.org                

Copyright © 2021 by Korean Medical Association.

Developed in M2PI

Close layer
prev next